Table 1.

Comparison of presentation features between treatment arm



Treatment arm



ABCM, no. (%)
CVAMP/HDM, no. (%)
Total, no.
P
Total   101   121   222   
Sex     
M   52 (52)   62 (51)   114   
F   49 (48)   59 (49)   108   .51  
Age, y     
31-40   7 (7)   1 (1)   8   
41-50   25 (24)   27 (22)   52   
51-60   50 (50)   68 (56)   118   
61-66   19 (19)   25 (21)   44   .09  
B2M level, mg/L     
Below 4   45 (45)   52 (43)   97   
4-8   30 (29)   37 (31)   67   
More than 8   22 (22)   28 (23)   50   
Unknown   4   4   8   .93  
Hemoglobin level, g/L     
Below 800   1300 (13)   1300 (11)   2600   
800-1000   2700 (26)   3600 (30)   6300   
More than 1000   5900 (59)   65 (54)   12 400   
Unknown   200   700   900   .75  
Creatinine level, μM     
Below 100   43 (43)   57 (47)   100   
100-200   44 (43)   49 (40)   93   
More than 200
 
14 (14)
 
15 (13)
 
29
 
.83
 


Treatment arm



ABCM, no. (%)
CVAMP/HDM, no. (%)
Total, no.
P
Total   101   121   222   
Sex     
M   52 (52)   62 (51)   114   
F   49 (48)   59 (49)   108   .51  
Age, y     
31-40   7 (7)   1 (1)   8   
41-50   25 (24)   27 (22)   52   
51-60   50 (50)   68 (56)   118   
61-66   19 (19)   25 (21)   44   .09  
B2M level, mg/L     
Below 4   45 (45)   52 (43)   97   
4-8   30 (29)   37 (31)   67   
More than 8   22 (22)   28 (23)   50   
Unknown   4   4   8   .93  
Hemoglobin level, g/L     
Below 800   1300 (13)   1300 (11)   2600   
800-1000   2700 (26)   3600 (30)   6300   
More than 1000   5900 (59)   65 (54)   12 400   
Unknown   200   700   900   .75  
Creatinine level, μM     
Below 100   43 (43)   57 (47)   100   
100-200   44 (43)   49 (40)   93   
More than 200
 
14 (14)
 
15 (13)
 
29
 
.83
 

P values are associated with Pearson chi-square statistic. B2M indicates β2-microglobulin.

Close Modal

or Create an Account

Close Modal
Close Modal